MedTrace Logo

Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit

NCT07414329 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-02-17

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if Sonova's rechargeable behind-the-ear hearing device kit works to treat hearing loss in adults. The main questions it aims to answer are:

* Does the rechargeable behind-the-ear hearing device kit address challenging listening situations identified by participants while providing a satisfactory user experience?
* Does the rechargeable behind-the-ear hearing device kit improve speech understanding in noise in a lab setting?

Researchers will compare participants' performance with the rechargeable behind-the-ear hearing device kit to the unaided condition to see if it works to treat hearing loss. The rechargeable behind-the-ear hearing device kit will be subjectively compared to their personal hearing device experience.

Participants will:

* Use the rechargeable behind-the-ear hearing device kit for approximately 2 weeks.
* Visit the clinic for the initial fitting and follow-up testing at the end of the study. Additional study visits may take place, as needed.
* Complete questionnaires to identify challenging listening situations and provide feedback on their experience with the devices.
* Complete lab testing to assess speech intelligibility in the presence of background noise and provide subjective feedback on features in the Mobile application.

Conditions

Interventions

DEVICE

Rechargeable behind-the-ear hearing device kit

This intervention includes the following components: hearing aid, charger, applicable accessories

Sponsors & Collaborators

  • National Hearing Services Inc

    collaborator UNKNOWN

  • Sonova AG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-30
Primary Completion
2026-03-31
Completion
2026-04-15

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07414329 on ClinicalTrials.gov